Telexos

Innovator•Germany

Health•Seed

Telexos, a German biotech start-up, has developed a next-generation liquid biopsy solution to detect cancer early and with high precision. Our proprietary technology isolates and analyzes rare circulating tumor cells (CTCs) from a simple blood sample – with unmatched sensitivity – providing unique insights into tumor biology. Highlights: Early and accurate cancer detection Enables personalized and targeted therapy decisions Reduces misdiagnosis, unnecessary treatments, and healthcare costs Supports faster and more effective oncology drug development